Me and the Peaks.
Release time:
2022-05-05
As time goes by, I communicate more and more with "Spike News" and like it more and more. Sometimes it is like a notepad, recording the bits and pieces of work and life, experiences and achievements of technological transformation. Sometimes it is like an emotional hotline, expressing personal thoughts and hearts. It is like a humble teacher who silently teaches us how to push ourselves and strive to improve. It is like a sincere friend, quietly sharing our joy, listening to our heartfelt confide.
I remember when I first came into contact with "Peak News", I just looked at the above report, appreciated the talents of others, and felt the achievements and joy of others. Although I really wanted to publish an article of my own at that time, I felt that there was still a gap in my writing level and lack of self-confidence, so I never dared to contribute. This emotion has been tangled, just like facing the object of unrequited love, dare not express the inner thoughts.
Finally one day, I plucked up the courage to cast my first manuscript since the 2008 entry spike. It was during the period of building a house in my hometown. Every time I came home to help after work, I watched my father break his heart day and night to build a house. Looking at his tired face, I suddenly remembered Mr. Zhu Ziqing's "Back" in the textbook of my school days. Suddenly there is a magical power to encourage me, very want to want to squeeze their feelings in the heart to tell, perhaps this is the so-called creative inspiration! To my surprise, the manuscript I submitted was published in the newspaper, and the joy at that time was beyond words.
Later, I combined what I saw and heard at work with my own thoughts and feelings to write and submit articles again and again, to carry forward the positive energy spirit of Daye Peak Enterprise, to encourage employees to be positive and upward, and to encourage employees to carry forward the spirit of dedication. Later, the technical transformation and the results of the technical transformation experienced in the process of work were submitted to share the experience of the transformation. As the number of submissions to the newspaper increased, my inner enthusiasm inspired me to continue to tap my potential.
"Peak News", thank you, your tolerance gives me the motivation to learn, and your variety adds elegant demeanour to my life. I will continue to work hard to improve and progress, and hope that I can closely integrate into the big family of "Peak News. (Huang Bide)
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31